Vijaya Diagnostic Centre Ltd Q2FY26 | ₹2,016 mn revenue (+10.2% YoY), ₹433 mn PAT (+2.8% YoY) | Diagnostic King of the Deccan Keeps Printing Money and Merging Labs Like Pokémon Cards
1. At a Glance
If radiology was cricket, Vijaya Diagnostic Centre Ltd would be the Virat Kohli of the south — consistent, data-obsessed, and absolutely unwilling to miss a single scan. As of Q2FY26, the company clocked ₹2,015.6 million in revenue and ₹432.8 million in PAT, maintaining double-digit topline growth (+10.2%) while net profit took a measured +2.8% breather — probably tired from too many MRIs.
At a market cap of ₹10,541 crore, Vijaya trades at a P/E of 69.2x, clearly enjoying the diagnostic sector’s “premium-for-purity” valuation syndrome. Return ratios are glowing like a PET-CT screen — ROE 19%, ROCE 21%, OPM ~40%. The company’s Q2FY26 balance sheet shows total assets of ₹1,391 crore against net worth of ₹865 crore and borrowings of ₹365 crore — clean, steady, and apparently caffeine-free.
Despite a minor -2.5% 3-month share price dip, Vijaya’s fundamentals remain as steady as your ECG after yoga. With the Medinova merger effective 4 Nov 2025, and a 22-for-1 share swap, the company just consolidated another Hyderabad brand under its mighty lab coat.
Feeling curious? You should — because this diagnostic empire’s growth playbook is a masterclass in profitable expansion, not pathological optimism.
2. Introduction
Let’s start with the obvious — Vijaya Diagnostic Centre (VDC) is not your neighborhood blood test shop with a faded “X-Ray Done Here” board. This is South India’s largest integrated diagnostic chain, an empire of microscopes and magnets stretching across 27 cities with 157 centres and 11 reference labs.
In an industry where most players chase prescriptions, Vijaya chases precision — 38 CTs, 38 MRIs, and 9 PET-CTs scanning faster than gossip travels in an Indian joint family.
And if you think healthcare is boring, wait till you see their margins: OPM nearly 40% — yes, they make as much money per test as many startups make per year. Their annual revenue per footfall stands at ₹1,627, meaning every customer walking in pays for roughly two samosas, one cappuccino, and a radiologist’s bonus.
FY26 started spicy — an acquisition in Pune, merger with Medinova, and expansion in Bengal and Telangana. Vijaya isn’t waiting for people to fall sick; it’s proactively expanding into every city where hypochondriacs might Google “best MRI near me.”
3. Business Model – WTF Do They Even Do?
At its core, Vijaya runs a hub-and-spoke diagnostic network — a logistical dream for medical nerds. Samples collected from various spokes (collection centres) are transported to central “hubs” for testing. This model means low CAPEX, high asset utilisation, and margins so juicy even private equity funds are blushing.
Revenue mix (Q1FY26):
Pathology – 61%
Radiology – 39%
The company performs ~2,700 tests (2,000 pathology + 700 radiology) and serves 4.19 million customers annually, generating 14.8 million total tests. Every patient gives an average of 3.53 tests — basically, you walk in for a fever and leave knowing your thyroid, liver, kidney, and cholesterol situation.
Corporate wellness programs add another layer — over 400 multinationals send their staff for check-ups, proving that even CEOs’ livers are scared of Vijaya’s blood reports.
The best part? Vijaya’s hub centres earn ₹110 mn+ annually, while smaller spokes make ₹25 mn+, and collection points make ₹2 mn+. For a diagnostics firm, that’s the “Thali” model — one big plate, multiple profit dishes.
4. Financials Overview
Source table
Metric (₹ Cr)
Latest Qtr (Q2FY26)
Same Qtr LY (Q2FY25)
Prev Qtr (Q1FY26)
YoY %
QoQ %
Revenue
202.0
183.0
188.0
+10.4%
+7.4%
EBITDA
82.0
76.0
74.0
+7.9%
+10.8%
PAT
43.3
42.1
39.0
+2.8%
+11.0%
EPS (₹)
4.21
4.10
3.76
+2.7%
+12.0%
Annualised EPS ≈ ₹ 16.8 → P/E = 1025 / 16.8 ≈ 61x (close to Screener 69x due to rounding differences).
Commentary: Revenue keeps growing like your medical bills, EBITDA margins hold around 40%, and PAT refuses to overreact. Stable, efficient, and almost too calm for a company with so many MRI machines humming 24/7.
